Matt Davies

1PUBLICATIONS
5CO-AUTHORS
Microbial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Feb 16, 2024
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.

Andreas H Diacon, Clifton E Barry, Alex Carlton

Pageof 1

Frequent Collaborators

1 joint publications

Clifton E Barry

1 joint publications

Gavin C K W Koh

1 joint publications

Christoph Lange

1 joint publications

Caryn M Upton

1 joint publications

David Barros Aguirre

Frequent Collaborators

1 joint publications

Clifton E Barry

1 joint publications

Gavin C K W Koh

1 joint publications

Christoph Lange

1 joint publications

Caryn M Upton

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>

Published on : Apr 05, 2017

8.6K
See more related videos

Top Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular <em>Mycobacterium tuberculosis</em>

Published on : Apr 05, 2017

8.6K
See more related videos